Isaac Ro

Direktor/Vorstandsmitglied bei SEER, INC.

Vermögen: 76 670 $ am 31.05.2026

48 Jahre

97 Beziehungen

Finance

Health Technology

Health Services

Profil

Isaac Ro is Executive Chairman at Haystack Oncology, Inc., Independent Director at Seer, Inc. (California) starting 2025, Director at Bioct Innovation Commons, and Partner at Catalio Capital Management LP since 2023.
Former roles include Director at Leerink Partners LLC from 2004 to 2010, Research Associate at Independence Investments LLC, Analyst at Goldman Sachs & Co. LLC.
from 2013 to 2019, Research Associate at Aberdeen Content LLC, Chief Financial Officer at Thrive Earlier Detection Corp.
from 2019 to 2021, and Chief Financial Officer at GeneDx Holdings Corp.
from 2021 to 2022.
Education includes an undergraduate degree from Middlebury College, conferred in 2000.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
SEER, INC. CLASS A 0,07 %	02.09.2025	41 000 ( 0,07 % )	76 670 $	31.05.2026

Aktive Positionen von Isaac Ro

Unternehmen	Position	Beginn
SEER, INC.	Direktor/Vorstandsmitglied	02.09.2025
Bioct Innovation Commons	Direktor/Vorstandsmitglied	-
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Vorsitzender	-
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Private Equity Investor	01.04.2023

Alle aktiven Positionen von Isaac Ro

Ehemalige bekannte Positionen von Isaac Ro

Unternehmen	Position	Ende
GENEDX HOLDINGS CORP.	Finanzdirektor/CFO	10.06.2022
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Finanzdirektor/CFO	01.02.2021
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01.06.2019
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31.05.2010
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Isaac Ro im Detail an

Ausbildung von Isaac Ro

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Isaac Ro im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Finance
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Aberdeen Content LLC Aberdeen Content LLC Miscellaneous Commercial ServicesCommercial Services Provides fact based research services	Commercial Services
Middlebury College Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Seer, Inc. (California) Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology	Health Technology
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Health Technology
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Finance
GeneDx Holdings Corp. GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services	Health Services
Bioct Innovation Commons	Finance
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Health Services